Delivery Order SPE2DB24D1021-SPE2DB24FERNE

Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $3.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of MENQUADFI VIAL 0.5ML medical supplies with a ceiling value of $7,591.93 and a period of performance ending on May 22, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of MENQUADFI VIAL 0.5ML, a medical product, and has a ceiling value of $54,850.80. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, including a medication with the description "MENQUADFI VIAL 0.5ML". The contract has a ceiling value of $141,856.00 and an ultimate completion date of September 8, 2022. The contract was awarded on September 7, 2022 and was not set aside for any particular business type. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $117,667.70, is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. The contract has a period of performance through March 2, 2023 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of pharmaceutical product "MENQUADFI VIAL 0.5ML" with a ceiling value of $5,712.31 and a period of performance through June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
This federal contract award, valued at $73,069.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the supply of MENQUADFI VIAL 0.5ML, a medical product, with a performance period ending on May 4, 2023. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
This is a $35,124 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565366340 MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a period of performance through August 7, 2024. The contract is not set aside for any particular business designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of prescription...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a ceiling value of $2,219.92 and is for the delivery order of "MENQUADFI VIAL 0.5ML". This contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
This $10,523.08 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENQUADFI VIAL 0.5ML medical products, with a period of performance through January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,185.32 fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award has an ultimate completion date of May 2, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FERNE
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including the specific item "MENQUADFI VIAL 0.5ML", with a ceiling value of $3,512.40 and a performance period ending on May 10, 2024. The contract does not have a set-aside designation.

Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, serving various defense and civilian agencies. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order is likely part of that larger IDC contract.

Generated 11/1/24, 9:32 AM